- Home
- CZR vs TGTX Comparison
CZR vs TGTX Comparison
Compare CZR & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZR
- TGTX
- Stock Information
- Founded
- CZR 1937
- TGTX 1993
- Country
- CZR United States
- TGTX United States
- Employees
- CZR N/A
- TGTX N/A
- Industry
- CZR Hotels/Resorts
- TGTX Biotechnology: Pharmaceutical Preparations
- Sector
- CZR Consumer Discretionary
- TGTX Health Care
- Exchange
- CZR Nasdaq
- TGTX Nasdaq
- Market Cap
- CZR 4.6B
- TGTX 5.5B
- IPO Year
- CZR 1989
- TGTX 1995
- Fundamental
- Price
- CZR $20.04
- TGTX $33.87
- Analyst Decision
- CZR Buy
- TGTX Strong Buy
- Analyst Count
- CZR 14
- TGTX 5
- Target Price
- CZR $37.86
- TGTX $48.20
- AVG Volume (30 Days)
- CZR 9.3M
- TGTX 1.8M
- Earning Date
- CZR 10-28-2025
- TGTX 11-03-2025
- Dividend Yield
- CZR N/A
- TGTX N/A
- EPS Growth
- CZR N/A
- TGTX N/A
- EPS
- CZR N/A
- TGTX 2.78
- Revenue
- CZR $11,369,000,000.00
- TGTX $531,898,000.00
- Revenue This Year
- CZR $3.17
- TGTX $82.31
- Revenue Next Year
- CZR $2.85
- TGTX $49.05
- P/E Ratio
- CZR N/A
- TGTX $12.18
- Revenue Growth
- CZR 0.87
- TGTX 100.88
- 52 Week Low
- CZR $18.25
- TGTX $22.92
- 52 Week High
- CZR $41.76
- TGTX $46.48
- Technical
- Relative Strength Index (RSI)
- CZR 37.96
- TGTX 49.40
- Support Level
- CZR $18.25
- TGTX $31.07
- Resistance Level
- CZR $20.87
- TGTX $36.65
- Average True Range (ATR)
- CZR 1.02
- TGTX 1.70
- MACD
- CZR -0.12
- TGTX -0.18
- Stochastic Oscillator
- CZR 40.43
- TGTX 50.09
About CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About TGTX TG Therapeutics Inc.
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.